Global intracranial hemorrhage diagnosis and treatment market information; by devices (invasive and non-invasive) by types (intracranial hemorrhage, cerebral hemorrhage, and other) by drugs (anti-hypertensive, others); by surgeries - Forecast to 2023
Pune, India -- (SBWIRE) -- 07/21/2017 -- Market highlights
Intracranial hemorrhage diagnosis and treatment market expected to grow at a CAGR of 6.1% owing to higher prevalence of brain disorders and trauma
Intracranial haemorrhage is bleeding in the brain due to trauma or medical conditions such as cancer, tumour etc. Generally loss of 10–15% of the total blood volume does not cause serious mental problems. Rising number of strokes has led to growing demand for intracranial haemorrhage monitors. The growing prevalence of hypertension across the world is a major risk factor for strokes. However there is severe need for product development to overcome the drawbacks of intracranial haemorrhage monitors such as bacterial infections and their invasive nature.
However the worsening regulatory and reimbursement environment combined with the uncertainty of healthcare reforms poses as a significant threat to the market. The U.S. food and drug administration (FDA) classifies medical devices into Class I, II, and III with regulatory control increasing from Class I to Class III, based on the need to provide reasonable assurance of its safety and effectiveness. Pre-market approval is needed for class II devices and most Class III devices and is a very cumbersome and time consuming process. Pre-market approval requires valid scientific evidence about the probable health benefits from the intended use of a device. Moreover these benefits must outweigh the probable risks and a reasonable evidence to assure that the device will significantly help a large portion of the target population. Pre-market approval increases in the time required for clearance of device by the FDA. The time for pre-market approval is increasing year by year which is a threat to intracranial haemorrhage monitors market.
Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/3687
Key players of Global intracranial hemorrhage diagnosis and treatment Market:
- Medtronic Plc.,
- Codman & Shurtleff, Inc.,
- Raumedic AG,
- Sophysa Ltd.,
- Orsan Medical Technologies,
- Spiegelberg GmbH,
- Johnson & Johnson,
- Sophysa Ltd,
- Head Sense Medical,
- InfraScan, Inc.,
- Integra Life Sciences Corporation
Global intracranial haemorrhage diagnosis and treatment market is divided, on the basis of regions into North America, Europe, Asia Pacific and Middle East and Africa. North America leads the global market for intracranial haemorrhage diagnosis and treatment which is led by the U.S. The reasons for the dominance of U.S. is the high per capita income, the faster uptake of new technology, better reimbursement than other countries etc. The presence of large technology companies and innovation ecology of the US is also an important driver of the market. However the increasing stringency for class III devices in the US coupled with rising time for approval of new devices with class III status is a threat to the future market.
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Global Intracranial Hemorrhage Diagnosis and Treatment Market Research Report- Forecast To 2023"
Browse full report @ https://www.marketresearchfuture.com/reports/intracranial-hemorrhage-diagnosis-and-treatment-market-3687
Table of Content
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market Dynamics
3.4 Macroeconomic Indicators
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Intracranial Hemorrhage Diagnosis And Treatment Market, By Devices
Key questions answered in this report
- What will the market size be in 2023 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
+1 646 845 9312